The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Absorbable Pain Relievers for External Use Market Research Report 2025
Synopsis
Global Absorbable Pain Relievers for External Use market is projected to reach US$ 13180 million in 2029, increasing from US$ 9305 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Absorbable Pain Relievers for External Use market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Absorbable Pain Relievers for External Use market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Johnson & Johnson
Novartis
Pfizer
GlaxoSmithKline
Reckitt Benckiser Group
Teikoku Pharma
Topical BioMedics
Sun Pharmaceutical Industries
AdvaCare Pharma
Segment by Type
Gel
Spray
Others
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Absorbable Pain Relievers for External Use report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Absorbable Pain Relievers for External Use market is projected to reach US$ 13180 million in 2029, increasing from US$ 9305 million in 2022, with the CAGR of 5.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Absorbable Pain Relievers for External Use market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Absorbable Pain Relievers for External Use market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Johnson & Johnson
Novartis
Pfizer
GlaxoSmithKline
Reckitt Benckiser Group
Teikoku Pharma
Topical BioMedics
Sun Pharmaceutical Industries
AdvaCare Pharma
Segment by Type
Gel
Spray
Others
Segment by Application
Hospital
Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Absorbable Pain Relievers for External Use report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Absorbable Pain Relievers for External Use Market Overview
1.1 Product Overview and Scope of Absorbable Pain Relievers for External Use
1.2 Absorbable Pain Relievers for External Use Segment by Type
1.2.1 Global Absorbable Pain Relievers for External Use Market Value Comparison by Type (2023-2029)
1.2.2 Gel
1.2.3 Spray
1.2.4 Others
1.3 Absorbable Pain Relievers for External Use Segment by Application
1.3.1 Global Absorbable Pain Relievers for External Use Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Absorbable Pain Relievers for External Use Market Size Estimates and Forecasts
1.4.1 Global Absorbable Pain Relievers for External Use Revenue 2018-2029
1.4.2 Global Absorbable Pain Relievers for External Use Sales 2018-2029
1.4.3 Global Absorbable Pain Relievers for External Use Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Absorbable Pain Relievers for External Use Market Competition by Manufacturers
2.1 Global Absorbable Pain Relievers for External Use Sales Market Share by Manufacturers (2018-2023)
2.2 Global Absorbable Pain Relievers for External Use Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Absorbable Pain Relievers for External Use Average Price by Manufacturers (2018-2023)
2.4 Global Absorbable Pain Relievers for External Use Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Absorbable Pain Relievers for External Use, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Absorbable Pain Relievers for External Use, Product Type & Application
2.7 Absorbable Pain Relievers for External Use Market Competitive Situation and Trends
2.7.1 Absorbable Pain Relievers for External Use Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Absorbable Pain Relievers for External Use Players Market Share by Revenue
2.7.3 Global Absorbable Pain Relievers for External Use Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Absorbable Pain Relievers for External Use Retrospective Market Scenario by Region
3.1 Global Absorbable Pain Relievers for External Use Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Absorbable Pain Relievers for External Use Global Absorbable Pain Relievers for External Use Sales by Region: 2018-2029
3.2.1 Global Absorbable Pain Relievers for External Use Sales by Region: 2018-2023
3.2.2 Global Absorbable Pain Relievers for External Use Sales by Region: 2024-2029
3.3 Global Absorbable Pain Relievers for External Use Global Absorbable Pain Relievers for External Use Revenue by Region: 2018-2029
3.3.1 Global Absorbable Pain Relievers for External Use Revenue by Region: 2018-2023
3.3.2 Global Absorbable Pain Relievers for External Use Revenue by Region: 2024-2029
3.4 North America Absorbable Pain Relievers for External Use Market Facts & Figures by Country
3.4.1 North America Absorbable Pain Relievers for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Absorbable Pain Relievers for External Use Sales by Country (2018-2029)
3.4.3 North America Absorbable Pain Relievers for External Use Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Absorbable Pain Relievers for External Use Market Facts & Figures by Country
3.5.1 Europe Absorbable Pain Relievers for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Absorbable Pain Relievers for External Use Sales by Country (2018-2029)
3.5.3 Europe Absorbable Pain Relievers for External Use Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Absorbable Pain Relievers for External Use Market Facts & Figures by Country
3.6.1 Asia Pacific Absorbable Pain Relievers for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Absorbable Pain Relievers for External Use Sales by Country (2018-2029)
3.6.3 Asia Pacific Absorbable Pain Relievers for External Use Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Absorbable Pain Relievers for External Use Market Facts & Figures by Country
3.7.1 Latin America Absorbable Pain Relievers for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Absorbable Pain Relievers for External Use Sales by Country (2018-2029)
3.7.3 Latin America Absorbable Pain Relievers for External Use Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Absorbable Pain Relievers for External Use Market Facts & Figures by Country
3.8.1 Middle East and Africa Absorbable Pain Relievers for External Use Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Absorbable Pain Relievers for External Use Sales by Country (2018-2029)
3.8.3 Middle East and Africa Absorbable Pain Relievers for External Use Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Absorbable Pain Relievers for External Use Sales by Type (2018-2029)
4.1.1 Global Absorbable Pain Relievers for External Use Sales by Type (2018-2023)
4.1.2 Global Absorbable Pain Relievers for External Use Sales by Type (2024-2029)
4.1.3 Global Absorbable Pain Relievers for External Use Sales Market Share by Type (2018-2029)
4.2 Global Absorbable Pain Relievers for External Use Revenue by Type (2018-2029)
4.2.1 Global Absorbable Pain Relievers for External Use Revenue by Type (2018-2023)
4.2.2 Global Absorbable Pain Relievers for External Use Revenue by Type (2024-2029)
4.2.3 Global Absorbable Pain Relievers for External Use Revenue Market Share by Type (2018-2029)
4.3 Global Absorbable Pain Relievers for External Use Price by Type (2018-2029)
5 Segment by Application
5.1 Global Absorbable Pain Relievers for External Use Sales by Application (2018-2029)
5.1.1 Global Absorbable Pain Relievers for External Use Sales by Application (2018-2023)
5.1.2 Global Absorbable Pain Relievers for External Use Sales by Application (2024-2029)
5.1.3 Global Absorbable Pain Relievers for External Use Sales Market Share by Application (2018-2029)
5.2 Global Absorbable Pain Relievers for External Use Revenue by Application (2018-2029)
5.2.1 Global Absorbable Pain Relievers for External Use Revenue by Application (2018-2023)
5.2.2 Global Absorbable Pain Relievers for External Use Revenue by Application (2024-2029)
5.2.3 Global Absorbable Pain Relievers for External Use Revenue Market Share by Application (2018-2029)
5.3 Global Absorbable Pain Relievers for External Use Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Absorbable Pain Relievers for External Use Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson & Johnson Absorbable Pain Relievers for External Use Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Absorbable Pain Relievers for External Use Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Absorbable Pain Relievers for External Use Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline Absorbable Pain Relievers for External Use Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Reckitt Benckiser Group
6.6.1 Reckitt Benckiser Group Corporation Information
6.6.2 Reckitt Benckiser Group Description and Business Overview
6.6.3 Reckitt Benckiser Group Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Reckitt Benckiser Group Absorbable Pain Relievers for External Use Product Portfolio
6.6.5 Reckitt Benckiser Group Recent Developments/Updates
6.7 Teikoku Pharma
6.6.1 Teikoku Pharma Corporation Information
6.6.2 Teikoku Pharma Description and Business Overview
6.6.3 Teikoku Pharma Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teikoku Pharma Absorbable Pain Relievers for External Use Product Portfolio
6.7.5 Teikoku Pharma Recent Developments/Updates
6.8 Topical BioMedics
6.8.1 Topical BioMedics Corporation Information
6.8.2 Topical BioMedics Description and Business Overview
6.8.3 Topical BioMedics Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Topical BioMedics Absorbable Pain Relievers for External Use Product Portfolio
6.8.5 Topical BioMedics Recent Developments/Updates
6.9 Sun Pharmaceutical Industries
6.9.1 Sun Pharmaceutical Industries Corporation Information
6.9.2 Sun Pharmaceutical Industries Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sun Pharmaceutical Industries Absorbable Pain Relievers for External Use Product Portfolio
6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.10 AdvaCare Pharma
6.10.1 AdvaCare Pharma Corporation Information
6.10.2 AdvaCare Pharma Description and Business Overview
6.10.3 AdvaCare Pharma Absorbable Pain Relievers for External Use Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AdvaCare Pharma Absorbable Pain Relievers for External Use Product Portfolio
6.10.5 AdvaCare Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Absorbable Pain Relievers for External Use Industry Chain Analysis
7.2 Absorbable Pain Relievers for External Use Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Absorbable Pain Relievers for External Use Production Mode & Process
7.4 Absorbable Pain Relievers for External Use Sales and Marketing
7.4.1 Absorbable Pain Relievers for External Use Sales Channels
7.4.2 Absorbable Pain Relievers for External Use Distributors
7.5 Absorbable Pain Relievers for External Use Customers
8 Absorbable Pain Relievers for External Use Market Dynamics
8.1 Absorbable Pain Relievers for External Use Industry Trends
8.2 Absorbable Pain Relievers for External Use Market Drivers
8.3 Absorbable Pain Relievers for External Use Market Challenges
8.4 Absorbable Pain Relievers for External Use Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
